177 related articles for article (PubMed ID: 1953117)
21. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
[TBL] [Abstract][Full Text] [Related]
23. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
[TBL] [Abstract][Full Text] [Related]
24. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma.
Badgwell B; Xing Y; Gershenwald JE; Lee JE; Mansfield PF; Ross MI; Cormier JN
Ann Surg Oncol; 2007 Oct; 14(10):2867-75. PubMed ID: 17671814
[TBL] [Abstract][Full Text] [Related]
25. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
Balch CM; Gershenwald JE; Soong SJ; Thompson JF; Ding S; Byrd DR; Cascinelli N; Cochran AJ; Coit DG; Eggermont AM; Johnson T; Kirkwood JM; Leong SP; McMasters KM; Mihm MC; Morton DL; Ross MI; Sondak VK
J Clin Oncol; 2010 May; 28(14):2452-9. PubMed ID: 20368546
[TBL] [Abstract][Full Text] [Related]
26. The value of Cloquet's node in predicting melanoma nodal metastases in the pelvic lymph node basin.
Strobbe LJ; Jonk A; Hart AA; Peterse JL; Wobbes T; Nieweg OE; Kroon BB
Ann Surg Oncol; 2001 Apr; 8(3):209-14. PubMed ID: 11314936
[TBL] [Abstract][Full Text] [Related]
27. Axillary Lymph Node Metastases of Melanoma: Management of Third-level Nodes.
Gentile D; Covarelli P; Picciotto F; Caliendo V; Stingeni L; Del Sordo R; Rulli A
In Vivo; 2016; 30(2):141-5. PubMed ID: 26912825
[TBL] [Abstract][Full Text] [Related]
28. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
29. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
31. Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation.
Iatì G; Pontoriero A; Mondello S; Santacaterina A; Platania A; Frosina P; Raso MM; Aiello D; Arcudi A; Arena G; Marino G; Mazzei M; Rifatto C; Risoleti E; Runco R; Sansotta G; Delia P; Sindoni A; Pergolizzi S
Anticancer Res; 2016 Jul; 36(7):3549-54. PubMed ID: 27354622
[TBL] [Abstract][Full Text] [Related]
32. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
34. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Ann Surg; 1981 Mar; 193(3):377-88. PubMed ID: 7212800
[TBL] [Abstract][Full Text] [Related]
35. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients.
Burger MP; Hollema H; Emanuels AG; Krans M; Pras E; Bouma J
Gynecol Oncol; 1995 Jun; 57(3):327-34. PubMed ID: 7774836
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma.
Ghaferi AA; Wong SL; Johnson TM; Lowe L; Chang AE; Cimmino VM; Bradford CR; Rees RS; Sabel MS
Ann Surg Oncol; 2009 Nov; 16(11):2978-84. PubMed ID: 19711133
[TBL] [Abstract][Full Text] [Related]
37. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
[TBL] [Abstract][Full Text] [Related]
38. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.
Hughes TM; A'Hern RP; Thomas JM
Br J Surg; 2000 Jul; 87(7):892-901. PubMed ID: 10931025
[TBL] [Abstract][Full Text] [Related]
39. Melanoma of unknown primary origin: a population-based study in the Netherlands.
de Waal AC; Aben KK; van Rossum MM; Kiemeney LA
Eur J Cancer; 2013 Feb; 49(3):676-83. PubMed ID: 23031553
[TBL] [Abstract][Full Text] [Related]
40. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
Kuerer HM; Sahin AA; Hunt KK; Newman LA; Breslin TM; Ames FC; Ross MI; Buzdar AU; Hortobagyi GN; Singletary SE
Ann Surg; 1999 Jul; 230(1):72-8. PubMed ID: 10400039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
